비즈니스 윤리 AI 컨설턴트

집

AI 프롬프트 목록

철학/종교

윤리적 의사결정 지원

${:__('collect %s',윤리적 의사결정 지원)}$

철학/종교

공리주의와 의무론 프레임워크를 기반으로 비즈니스 윤리적 딜레마에 대한 다차원적 도덕적 평가와 조언을 제공합니다.

프롬프트 내용

복사

Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company discovers during clinical trials that a drug has minor but long-term neurological side effects, yet it significantly extends the survival of late-stage cancer patients with no alternative therapies. Please analyze how the company should balance shareholder interests, patient health rights, and social responsibility by combining the utilitarian principle of maximizing happiness with the deontological perspective of respecting patient autonomy and the duty of non-maleficence, specifically regarding whether informed consent forms should explicitly mention these side effects, and provide specific communication strategies and ethical decision-making advice ensuring rigorous logic and compliance with modern business ethics standards.

복사

시니어 기업 윤리 고문으로서 다음 구체적인 비즈니스 시나리오에 대한 도덕적 추론을 수행하십시오: 제약 회사가 임상 시험 중 대체 요법이 없는 말기 암 환자의 생존 기간을 크게 연장할 수 있는 약물이지만 경미하지만 장기적인 신경계 부작용을 가진 약물을 발견하는 경우. 공리주의의 행복 최대화 원칙과 환자의 자율성을 존중하고 해를 끼치지 않아야 한다는 의무론적 관점을 결합하여, 정보 동의서에 이러한 부작용을 명시적으로 기재해야 하는지 여부를 포함하여 주주의 이익, 환자의 건강권, 사회적 책임을 어떻게 균형 있게 조정해야 하는지 분석하고, 현대 비즈니스 윤리 기준을 준수하는 엄격한 논리와 구체적인 커뮤니케이션 전략, 윤리적 의사결정 조언을 제공하십시오.

복사

공유 링크를 복사하려면 클릭

의견 (0)

0/300

제출하다

추천

윤리적 의사결정 지원

Act as a senior corporate ethics consultant to conduct a deep moral assessment of the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has mild but irreversible neurological side effects with long-term use, yet discontinuing the drug would cause severe deterioration for many chronic patients. Please analyze the trade-offs between disclosing information, adjusting pricing, developing alternatives, and assuming social responsibility by integrating utilitarian impacts on overall well-being with deontological respect for patient autonomy and the principle of non-maleficence. Provide a comprehensive action plan that balances commercial sustainability with moral integrity, focusing on how to protect patient rights while ensuring the company's long-term viability.

윤리적 의사결정 지원

Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that a rare side effect of its marketed drug may cause serious health risks with long-term use, but recalling it would lead to bankruptcy and affect thousands of employees' livelihoods, while concealing it violates patient safety principles. Please evaluate the moral weight of three options—public disclosure, partial recall, or complete concealment—by combining the utilitarian view of the greatest happiness for the greatest number with the deontological view of respecting individual rights and the duty of honesty, and provide a specific action recommendation that balances social responsibility and corporate survival, ensuring the decision-making process is transparent and compliant with business ethics norms.

윤리적 의사결정 지원

Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but under-disclosed side effects with long-term use. Continuing sales increases profit but may harm some patients, while recalling it causes massive losses and job cuts. Please evaluate the moral weight of both paths by combining the impact on overall well-being from utilitarianism with the emphasis on the duty of honest disclosure from deontology, and provide a balanced recommendation that considers legal compliance, corporate survival, and social responsibility, avoiding absolute moral judgments and instead offering a decision framework based on stakeholder analysis.

윤리적 의사결정 지원

Act as a corporate ethics consultant to conduct a deep moral analysis of the following specific business scenario: A pharmaceutical company discovers that its high-profit, already marketed drug has minor but long-term side effects. Recalling it would cause massive financial losses and affect shareholder interests, but not recalling it might harm some patients' health. Please evaluate the ethical weights of both recall and non-recall choices by combining two philosophical frameworks: utilitarianism (greatest happiness for the greatest number) and deontology (moral nature of the act itself, such as honesty and non-maleficence). Avoid simple binary judgments; instead, derive the best action path that is morally defensible and aligns with long-term Corporate Social Responsibility (CSR) by weighing the interests of various stakeholders (patients, shareholders, employees, society), and explain the reasoning.

윤리적 의사결정 지원

Act as a corporate ethics consultant to evaluate the following business scenario: A pharmaceutical company discovers its best-selling drug has minor but negligible side effects with long-term use, yet concealing this information would cause a stock crash and impact employee benefits. Analyze the moral risks of concealment using both utilitarian consequentialism and Kantian deontology, weigh shareholder interests against patient safety, and provide a decision recommendation that balances compliance with corporate social responsibility, ensuring logical consistency and adherence to business ethical standards.

윤리적 의사결정 지원

Act as a senior corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company developing a life-saving drug faces a dilemma regarding whether to partially release clinical trial data to accelerate approval, potentially sacrificing some subjects' privacy for greater public health benefits. Combine the utilitarian principle of maximizing happiness with the deontological respect for individual rights to evaluate the ethical risks of this decision. Provide a balanced solution that considers legal compliance, social responsibility, and long-term brand reputation, avoiding simple binary judgments, and focus on how to balance procedural justice with outcome justice.